Penetration rate of the placement of a drug-eluting stent for the treatment of superficial femoral artery lesions in Japan-Reference-Cited by-同舟云学术

Penetration rate of the placement of a drug-eluting stent for the treatment of superficial femoral artery lesions in Japan

Published:2017-04-27 Issue:9 Volume:32 Page:1093-1098
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Mori Shinsuke,Hirano Keisuke,Yamauchi Yasutaka,Hayashi Eijiro,Doijiri Tatsuki,Takamura Takeshi,Maeda Atsuo,Okuda Jun,Mizuno Koichi,Onishi Yuko,Iwaki Taku,Tsukahara Kengo,Shinozaki Norihiko,Araki Hiroshi,Kongoji Ken,Sugano Teruyasu,Miyamoto Akira,Michishita Ichiro

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/article/10.1007/s00380-017-0982-7/fulltext.html

Reference24 articles.

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45:S5–S67

2. Tendera M, Aboyans V, Bartelink ML, Baumqartner I, Clément D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M (2011) ESC Committee for Practice Guidelines. ESC guidelines on the diagnosis and treatment of peripheral artery disease: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of European Society of Cardiology (ESC). Eur Heart J 32:2851–2906

3. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E (2007) Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115:2745–2749

4. Dick P, Wallner H, Sabeti S, Loewe C, Mlekusch W, Lammer J, Koppensteiner R, Minar E, Schillinger M (2009) Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv 74:1090–1095

5. Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, Shyder SA, O’Leary EE, Tepe G, Scheinert D, Zeller T, Investigators Zilver PTX (2013) Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol 61:2417–2427

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different drugs in drug-eluting stents for peripheral artery disease: a systematic evaluation and Bayesian meta-analysis;Journal of Thrombosis and Thrombolysis;2024-01-28

2. Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries;PLOS ONE;2023-09-21

3. Increase in skin perfusion pressure predicts amputation-free survival after lower extremity bypass surgery for critical limb ischemia;Vascular Medicine;2018-04-23